Heparinized saline vs normal saline for maintenance of intravenous access in neonates: An evidence-based practice change

Advances in Neonatal Care

Volumn 11, Issue 3, 2011, Pages 208-215

  Cook, Linda ^a   Bellini, Sandra ^b   Cusson, Regina M ^b  

^a DANBURY HOSPITAL   (United States)

^b UNIVERSITY OF CONNECTICUT   (United States)

Author keywords

Heparin; IV Access; IV Lock; Neonate; Normal Saline

Indexed keywords

ANTICOAGULANT AGENT; HEPARIN; SODIUM CHLORIDE;

ANALYSIS OF VARIANCE; ARTICLE; CATHETERIZATION; EVALUATION; EVIDENCE BASED NURSING; HUMAN; INDWELLING CATHETER; INTRAVENOUS DRUG ADMINISTRATION; MEDICAL RECORD; METHODOLOGY; NEWBORN; STANDARD; TREATMENT OUTCOME; UNITED STATES;

ANALYSIS OF VARIANCE; ANTICOAGULANTS; CATHETERIZATION, PERIPHERAL; CATHETERS, INDWELLING; EVIDENCE-BASED NURSING; HEPARIN; HUMANS; INFANT, NEWBORN; INFUSIONS, INTRAVENOUS; MEDICAL RECORDS; NEW ENGLAND; SODIUM CHLORIDE; TREATMENT OUTCOME;

EID: 79960230490     PISSN: 15360903     EISSN: None     Source Type: Journal    
DOI: 10.1097/ANC.0b013e31821bab61     Document Type: Article

References (22)

1. Ashton J, Gibson V, Summers S. Effects of heparin versus saline solution in intermittent infusion device irrigation. Heart Lung. 1990;19:608-612.
2. Geritz MA. Saline versus heparin in intermittent infuser patency maintenance. West J Nurs Res. 1992;14:131-141.
3. Hanrahan KS, Kleiber C, Berends S. Saline for peripheral intravenous locks in neonates: evaluating a change in practice. Neonatal Netw. 2000;19(2):19-24.
4. Heilskov J, Kleiber C, Johnson K, Miller J. A randomized trial of heparin and saline for maintaining intravenous locks in neonates. J Soc Pediatr Nurs. 1998;3(3):111-116.
5. Kotter RW. Heparin vs. saline for intermittent intravenous device maintenance in neonates. Neonatal Netw. 1996;15(6):43-47.
6. Nelson TJ, Graves SM. 0.9% sodium chloride injection with and without heparin for maintaining peripheral indwelling intermittent-infusion devices for infants. Am J Health Syst Pharm. 1998;55:570-573. (Pubitemid 28129019)
7. Paisley MK, Stamper M, Brown J, Brown N, Ganong LH. The use of heparin and normal saline flushes in neonatal intravenous catheters. Pediatr Nurs. 1997;23(5):521-527.
8. Schultz AA, Drew D, Hewitt H. Comparison of normal saline and heparinized saline for patency of IV locks in neonates. Appl Nurs Res. 2002;15(1):28-34. (Pubitemid 40433124)
9. Malloy MH, Cutter GR. The association of heparin exposure with intraventricular hemorrhage among very low birth weight infants. J Perinatol. 1995;15:185-191.
10. Garrelts JC. White clot syndrome and thrombocytopenia: reasons to abandon heparin IV lock solution. Clin Pharmacol. 1992;11(9):797-799.
11. Otoya M. Heparin safety in the neonatal intensive care unit: are we learning from mistakes of others? Newb Inf Nurs Rev. 2009;9(I):53-61.
12. The Joint Commission Preventing errors relating to commonly used anticoagulants. Sentinel Event Alert. http://www.jointcommission.org/ SentinelEvents/ SentinelEventsAlert/sea-41.htm. Published 2008. Accessed March 2, 2009.
13. Ilin R-G II, Watanabe T. Hospital drug errors far from uncommon. Archives of the Los Angeles Times. http://www.latimes.com/news/nationworld/world/la- metwins22nov22,0,5019043.story. Accessed March 2, 2009.
14. The Joint Commission. National patient safety goals 2008. http://www.joint commission.org/PatientSafety/NationalPatientSafety Goals2008. Accessed March 2, 2009.
15. ASHP Position Paper. ASHP Therapeutic Position Statement on the institutional use of 0.9% sodium chloride injection to maintain patency of peripheral indwelling intermittent infusion devices (ASHP Commission on Therapeutics). Am J Health Syst Pharma. 2006;63(13):1273-1275.
16. US Federal Drug Administration. Baxter Issues Urgent Nationwide Voluntary Recall of Heparin 1, 000 Units/ml 10 and 30 ml Multi-Dose Vials, 2008. FDA Firm Recalls Information Web site: http://www.fda.gov/oc/po/firmrecalls/baxter0108. html. Accessed March 2, 2009.
17. Mudge B, Forcier D, Slattery M. Patency of 24-gauge peripheral intermittent infusion devices: a comparison of heparin and saline flush solutions. Pediatr Nurs. 1998;24(2):142-149.
18. Coyle LA, Sokop AG. Innovation adoption among nurses. Nurs Res. 1990;39(3):176-180.
19. Classen DC, Pestotnik SL, Evans RS, et al. Adverse drug events in hospitalized patients. JAMA. 1997;277(4):301-306.
20. Sharek PJ, Horbar JD, Mason W, et al. Adverse events in the neonatal intensive care unit: development, testing, and findings of an NICU-focused trigger tool to identify harm in North American NICUs. Pediatrics. 2006;118:1332-1340. (Pubitemid 46393776)
21. Payscale. http://www.payscale.com/mypayscale.aspx?pid=248f29d6-90ed-4354- b53d-279ce6c4a256. Accessed April 27, 2010.
22. Arnand K. Clinical importance of pain and stress in preterm infants. Biol Neonate. 1998;73:1-9.